Prescription drug wholesaler pleads guilty to smuggling counterfeit cancer drugs
The FDA recently reported that the owner of a Turkish drug wholesaler has pleaded guilty to charges of smuggling misbranded and adulterated cancer treatment drugs into the United States. Sabahaddin Akman, owner of the Turkish firm Ozay Pharmaceuticals, pleaded guilty in the U.S. District Court for the Eastern District of Missouri, to smuggling counterfeit cancer drugs including multiple shipments of Altuzan, the Turkish version of bevacizumab (Avastin, Genentech).
The drugs did not meet FDA standards and had not been approved for distribution in the United States. The FDA’s Office of Criminal Investigations organized an international investigation that led to Akman’s arrest in Puerto Rico in January 2014. The investigation identified Akman and his company as a source of Altuzan.
Related Posts
In brief: Yet more seizures in NFL fakes crackdown
Over the last week, federal agents in the US have seized $1.5m worth of...
Illicit Trade in Tobacco Products: Stubbing Out an Unending Scourge
Dominated globally by organised crime, the illicit tobacco trade could be said to...
Revenue seizes tobacco products worth almost €1.4 million in Rosslare Europort
REVENUE officers seized tobacco products worth €1,396,000 in Rosslare Europort,...
India’s coastal security: An assessment
Coastal preparedness is better than earlier — but the overall picture remains...